Nuclear Antigen anticorps
Aperçu rapide pour Nuclear Antigen anticorps (ABIN7658080)
Antigène
Voir toutes Nuclear Antigen (IPO-38) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- IPO-38(IPO-38)
-
Attributs du produit
- Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin's disease and non-Hodgkin's lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 may be a useful marker of cell proliferation during monitoring of tumor progression. This antibody is available purified with BSA/azide at 200 μg/mL, or BSA/azide-free at 1 mg/mL.
-
Immunogène
- Spleen cells of a patient with hairy cell leukemia
-
Isotype
- IgM, kappa
-
-
-
-
Indications d'application
- Immunofluorescence 0.5-1 μg/mL. Flow Cytometry 0.5-1 μg/million cells/0.1 mL
-
Commentaires
-
Positive Control: Raji and PHA-stimulated (>12 hours) human or mouse lymphocytes. Breast and colorectal carcinomas.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, no BSA, no azide
-
Agent conservateur
- Without preservative
-
Stock
- -20 °C
-
Stockage commentaire
-
Stable at room temperature or 37°C for 7 days.
Store at -20 °C. Protect fluorescent conjugates from light
-
Date de péremption
- 24 months
-
-
- Nuclear Antigen (IPO-38)
-
Autre désignation
- IPO-38
-
Sujet
-
Synonyms: Not Known
Tissue Expression: Proliferating cells
-
Poids moléculaire
- 14-16 kDa
Antigène
-